Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04950153

Intensive Combination Approach to Rollback the Epidemic in Nigerian Adolescents: UH3 Phase

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
558 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
15 Years – 24 Years
Healthy volunteers
Accepted

Summary

Combination interventions with mHealth and Peer Navigation components will be evaluated in a randomized, stepped wedge trial among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study findings will demonstrate whether or not the combination interventions for HIV testing and linkage to care and for HIV treatment outcomes, which were found to be efficacious in our prior pilot UG3 trial, will remain efficacious if scaled as proposed in this UH3 trial, across multiple sites.

Detailed description

A randomized stepped wedge (cluster) trial will be conducted to investigate two combination interventions (each with mHealth + Peer Navigation components) among youth in Ibadan, Lagos, Sagamu, and Jos, Nigeria. Study 1 (Testing and Linkage to Care) will test a combination intervention that targets HIV testing and linkage to care. Study 2 (Treatment Intervention) will test a combination intervention that targets HIV treatment outcomes (retention, adherence and viral suppression).

Conditions

Interventions

TypeNameDescription
BEHAVIORALPeer navigationPeer navigators will navigate youth with HIV to provide assistance and support to optimize adherence to antiretroviral treatment (ART)
BEHAVIORALSMS Text messagingShort Message System (SMS) text messages to remind and encourage youth to adhere to their ART
BEHAVIORALSocial Media EngagementHIV testing outreach using social media platforms to promote HIV testing.
BEHAVIORALTesting Peer NavigationPeer navigators will conduct HIV testing outreach and linkage to care to at-risk youth

Timeline

Start date
2021-04-15
Primary completion
2024-08-30
Completion
2024-12-31
First posted
2021-07-06
Last updated
2024-10-15

Locations

6 sites across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT04950153. Inclusion in this directory is not an endorsement.